Welcome to LookChem.com Sign In|Join Free
  • or
3-(2-methoxy-4-methylphenyl)propanoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

53005-62-2

Post Buying Request

53005-62-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53005-62-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 53005-62-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,0,0 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 53005-62:
(7*5)+(6*3)+(5*0)+(4*0)+(3*5)+(2*6)+(1*2)=82
82 % 10 = 2
So 53005-62-2 is a valid CAS Registry Number.

53005-62-2Downstream Products

53005-62-2Relevant academic research and scientific papers

Total synthesis of the proposed structure of Anti-TMV active tabasesquiterpene A

Kumari, Anusueya,Suresh, Muthiah,Singh, Raj Bahadur

, (2021)

The proposed structure of Tabasesquiterpene A, an illudalane type of sesquiterpene has been synthesized in twelve steps from 2-methoxy-4-methylbenzaldehyde in 40% overall yield. Triflic acid mediated intramolecular Freidel-Crafts acylation allows to develop the critical indanone moiety, a key intermediate of this synthesis. A careful ortho-selective formylation and subsequent Knoevenagel condensation to incorporate three carbon side chain, followed by reduction, formation of tricyclic lactone and DIBAL-H supported reduction of lactone to target were other key transformation involved. The NMR spectroscopic data of the synthetic sample differ from those of natural tabasesquiterpene A.

MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF

-

, (2021/01/23)

The disclosure relates to compounds and pharmaceutical compositions capable of modulating the hydroxysteroid 17-beta dehydrogenase (HSD17B) family member proteins including inhibiting the HSD17B member proteins, e.g. HSD17B13. The disclosure further relates to methods of treating liver diseases, disorders, or conditions with the compounds and pharmaceutical compositions disclosed herein, in which the HSD17B family member protein plays a role.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 53005-62-2